Skip to main content

Table 1 Inclusion and Exclusion Criteria

From: Transfusion of red cells in hematopoietic stem cell transplantation (TRIST): study protocol for a randomized controlled trial

 

Inclusion Criteria

1

   Males or females aged 18 years or older who are undergoing either an autologous or allogeneic HSCT.

2

The indications for HSCT may include, but not limited to the following diseases:

a. Acute Leukemia, myeloid, lymphoid or biphenotypic in 1st, 2nd remission or in relapse

b. Chronic Myeloid Leukemia in chronic, accelerated or blast phase

c. Chronic Lymphocytic Leukemia

d. Myelodysplastic Syndrome

e. Myeloproliferative Disorder

f. Lymphoma

g. Myeloma

3

   All study patients must provide consent at least 1 day prior to scheduled HSCT and provide written informed consent.

 

Exclusion Criteria

1

   Pregnant or lactating at the time of enrollment.

2

   Already received red cell transfusion after conditioning chemotherapy for HSCT but prior to enrollment.

3

   Unable/unwilling to providing informed consent.

4

   Geographically inaccessible